Home > Journals > Journal of Enzyme Inhibition and Medicinal Chemistry Impact Factor, Quartile, Indexing, Ranking
Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by Taylor & Francis. The Print-ISSN of Journal of Enzyme Inhibition and Medicinal Chemistry is 14756366
The Publication fees (APC) is 4165 AUD; 2875 EUR; 2392 GBP; 2990 USD.
Journal of Enzyme Inhibition and Medicinal Chemistry is published by Taylor & Francis, based in United Kingdom, publishing since 2017. It covers research in Pharmacology, Toxicology and Pharmaceutics.
Topics covered include enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology.
The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.
Article processing charge: 4165 AUD; 2875 EUR; 2392 GBP; 2990 USD.
For full aims and scope, see the journal's official page.
| Journal title | Journal of Enzyme Inhibition and Medicinal Chemistry (JEIMC) |
| Print ISSN | 14756366 |
| Online ISSN | 14756374 |
| Publisher Name | Taylor & Francis |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Journal of Enzyme Inhibition and Medicinal Chemistry
| Article Publication Charges (APC) |
4165 AUD; 2875 EUR; 2392 GBP; 2990 USD ✳️Without APC Pharmacology, Toxicology and Pharmaceutics Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.